CAR-T Cell Therapy for ALL

Clinical trial NCT07695012 · RECRUITING

Trial details

NCT number: NCT07695012
Sponsor: Dr. Zaineb Akram
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed Acute Lymphoblastic Leukemia (ALL)

Start date: 2026-06-01
Primary completion: 2027-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.